We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Uncovering the impact of nano- and microplastics on neurodegenerative diseases and strategies to mitigate their damage
AI summary Read the abstract
Researchers reviewed evidence that micro- and nanoplastics may contribute to the progression of Alzheimer's and Parkinson's diseases by triggering brain inflammation, disrupting mitochondria (the cell's power source), and damaging the blood-brain barrier. The review also found that natural compounds like melatonin and probiotics show early promise in reducing some of these harmful effects.
Introduction.Microplastics (MPLs) are described as synthetic polymer particles with dimensions below 5 mm.Within this group, particles measuring less than 1 m are referred to as nanoplastics (NPLs).These particles are extensively distributed in the environment and have been identified in human food sources as well as in both groundwater and tap water.Objective.The aim of this review is to analyze the effect of micro-and nanoplastics on Alzheimer's and Parkinson's diseases.Furthermore, possible approaches to reducing the physiological effects of these particles are explored.Brief description of the state of knowledge.Analysis suggests that the accumulation of nano-and microplastics may contribute to the progression of conditions such as Alzheimer's and Parkinson's diseases.Observed effects, such as neuroinflammation, mitochondrial dysfunction and bloodbrain barrier disruption, suggest that neurotoxicity arises from multiple interacting pathways.Various bioactive substances have shown potential in reducing the neurotoxic impact of exposure to MNPs/NPLs.Melatonin, Fibroblast Growth Factor 1, and Camellia pollen have demonstrated promising effects in alleviating neurotoxicity.Furthermore, probiotics may play a role by restoring the natural balance of gut microbiota.Summary.The reviewed studies suggest that microplastics and nanoplastics may have a significant impact on neurodegenerative diseases, particularly Alzheimer's and Parkinson's disease.Further investigations into pharmacological treatments and therapeutic approaches to counteract the toxic effects of these pollutants on the human body are essential.In the long term, such research will improve patients quality of life and support the development of preventive strategies.
More Papers Like This
Microplastics and Nanoplastics as Potential Contributors to Neurodegenerative Disease: Mechanistic Links to Dementia, Parkinson's Disease, Epilepsy, and Emerging Therapeutic Opportunities
AI summary Read the abstract
Researchers review how microplastics and nanoplastics may reach the brain via inhalation and systemic routes, proposing that chronic neuroinflammation, oxidative stress, and direct interactions with proteins like amyloid-β and α-synuclein could link particle exposure to Alzheimer's, Parkinson's, and other neurodegenerative conditions.
Microplastics and Nanoplastics as Potential Contributors to Neurodegenerative Disease: Mechanistic Links to Dementia, Parkinson's Disease, Epilepsy, and Emerging Therapeutic Opportunities
AI summary Read the abstract
Researchers reviewed emerging evidence that micro- and nanoplastics may contribute to neurodegeneration by promoting neuroinflammation, oxidative stress, blood-brain barrier disruption, and direct interactions with aggregation-prone proteins like amyloid-β and α-synuclein, proposing that pre-existing neurological disease may increase susceptibility to particulate accumulation in brain tissue.
The role of microplastics exposure in Alzheimer’s and Parkinson’s disease
AI summary Read the abstract
Researchers reviewed the mechanistic links between microplastic and nanoplastic exposure and the two most common neurodegenerative diseases — Alzheimer's and Parkinson's — finding evidence that oxidative stress, neuroinflammation, blood-brain barrier disruption, and protein aggregation are key pathways connecting plastic pollution to neurodegeneration.
From the Environment to Molecular Interactions of Nanoplastics: Unraveling the Neurotoxic Impacts and the Implications in Neurodegenerative Processes
AI summary Read the abstract
This review examines how nanoplastics can cross the blood-brain barrier and potentially contribute to brain damage and neurodegenerative diseases like Alzheimer's and Parkinson's. Nanoplastics have been found in food, water, and air, and once they reach the brain they can trigger inflammation, oxidative stress, and protein misfolding. The review calls for more realistic lab studies and better detection methods to understand the true scope of nanoplastic effects on brain health.
Nano- and Microplastics in the Brain: An Emerging Threat to Neural Health
AI summary Read the abstract
This review summarizes evidence that nano- and microplastics can cross the blood-brain barrier and accumulate in brain tissue, where they trigger oxidative stress, inflammation, and protein clumping linked to diseases like Alzheimer's and Parkinson's. The findings suggest that plastic particles may also interfere with the brain's ability to heal from injury, though long-term human studies are still lacking.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.